CompletedNot Applicable

Efficacy of Aleo Vera Use in Prevention and Treatment of Chemotherapy-Induced Oral Mucositis in a Group of Egyptian Children with Acute Leukemia

Egypt40 participantsStarted 2023-03-07

Plain-language summary

evaluatation the efficacy of Aleovera in prevention and treatment of chemotherapy-induced oral mucositis in children suffering from acute leukemia in terms of appearance and severity

Who can participate

Age range3 Years – 13 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients suffering from Acute leukemia( Acute Lymphocytic Leukemia ).
✓. Patients scheduled for chemotherapy treatment.
✓. Patients who range from 3 to 13 years old.

What they're measuring

Prevention of oral mucositis

Timeframe: 2 months

Trial details

NCT IDNCT06757270

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-03-07

View on ClinicalTrials.gov More Oral Mucositis trials